Webcast is Live at 4 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Apr. 28, 2016--
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and
in vitro diagnostic technologies to the healthcare industry, today
announced that it will host a live webcast of its second quarter fiscal
2016 conference call on Monday, May 2, at 4 p.m. CT (5 p.m. ET). The
Company will issue an earnings news release after the market closes that
afternoon.
Gary Maharaj, president and chief executive officer, and Andy LaFrence,
vice president of finance and chief financial officer, will recap the
second quarter 2016 financial results and accomplishments. To access the
webcast, go to the investor relations portion of the Company’s website
at www.surmodics.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7 p.m. CT on Monday, May
2, until 7 p.m. CT on Monday, May 9, by registering for the replay at https://jsp.premiereglobal.com/webrsvp
using replay passcode 8501461. In addition, the conference call audio
and transcript will be archived on the Company’s website following the
call.
About Surmodics, Inc.
Surmodics is known as the global leader in surface modification
technologies for intravascular medical devices and a leading provider of
chemical components for in vitro diagnostic (IVD) tests and microarrays.
Following two recent acquisitions of Creagh Medical and NorMedix, the
company is executing on a key growth strategy for its medical device
business by expanding to offer total intravascular product solutions to
its medical device customers. The combination of proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities, enables Surmodics to significantly increase
the value it offers with highly differentiated intravascular solutions
designed and engineered to the most demanding requirements. With this
focus on offering total solutions, Surmodics’ mission remains: to
improve the detection and treatment of disease by using our technology
to provide solutions to difficult medical device and diagnostic
challenges. Surmodics is headquartered in Eden Prairie, Minnesota. For
more information about the company, visit www.surmodics.com.
The content of Surmodics’ website is not part of this press release or
part of any filings that the company makes with the SEC.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160428007056/en/
Source: m, Inc.
Surmodics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com
